Business Description
Noxopharm Ltd
ISIN : AU000000NOX9
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.92 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EPS without NRI Growth Rate | -194.3 | |||||
3-Year FCF Growth Rate | 23 | |||||
3-Year Book Growth Rate | -19.8 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
12-1 Month Momentum % | -77.27 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 12.79 | |||||
Quick Ratio | 12.79 | |||||
Cash Ratio | 10.32 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -11.1 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -105.92 | |||||
ROA % | -92.81 | |||||
ROIC % | -204.85 | |||||
ROC (Joel Greenblatt) % | -1276.03 | |||||
ROCE % | -104.15 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 2.91 | |||||
Price-to-Tangible-Book | 3 | |||||
EV-to-EBIT | -0.63 | |||||
EV-to-EBITDA | -0.63 | |||||
EV-to-FCF | -1.24 | |||||
Price-to-Net-Current-Asset-Value | 3 | |||||
Price-to-Net-Cash | 3 | |||||
Earnings Yield (Greenblatt) % | -158.73 | |||||
FCF Yield % | -32.64 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:NOXOF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Noxopharm Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -0.028 | ||
Beta | 0.09 | ||
Volatility % | 85.24 | ||
14-Day RSI | 0 | ||
14-Day ATR ($) | 0.000007 | ||
20-Day SMA ($) | 0.03 | ||
12-1 Month Momentum % | -77.27 | ||
52-Week Range ($) | 0.021 - 0.132 | ||
Shares Outstanding (Mil) | 292.24 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Noxopharm Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Noxopharm Ltd Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Noxopharm Ltd Frequently Asked Questions
What is Noxopharm Ltd(NOXOF)'s stock price today?
When is next earnings date of Noxopharm Ltd(NOXOF)?
Does Noxopharm Ltd(NOXOF) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |